Introduction
Metallothioneins (MTs) are a group of low molecular weight heavy metal binding proteins, unique in their high cysteine content. MTs specifically bind heavy metals such as zinc, cadmium, copper and mercury (1) . MTs were discovered in 1957 by Margoshes and Valee (2) , who have isolated a Cd2+ and Zn2+ binding protein from horse kidney. In 1966 Pulido et al. (3) isolated MTs from human liver. Since then, MTs were isolated and characterized from a larger number of species.
In 1964, Piscator (4) found that MT was present in elevated levels in the liver of rabbits exposed to cadmium. He postulated that the biosynthesis of the protein is induced by Cd2+ and that MT acts as a detoxifying agent by binding of Cd2+. The induction of MTs after administration of various heavy metal ions was demonstrated in many different animal species and in cultured cells (1) . In 1979 Karin and Herschman (5) In this paper, we will review our studies concerning the structure and expression of the genes encoding MTs in man.
Structure of the Human MT Gene Family
Tb define the structure and understand the regulation of human MT genes, it was necessary to obtain cDNA clones of human MT mRNA. A good source of human MT mRNA are HeLa cells which were found to express high levels of MTs in response to Cd2+ (6) . We have constructed a cDNA library from Cd2+ induced HeLa cells and by differential hybridization isolated a number of cDNA clones which preferentially hybridized to mRNA from Cd2+ induced cells. Using a mouse MT-I cDNA clone (7), we have identified among those clones several cDNA clones of human MT mRNA. The full nucleotide sequence of one of the clones was determined and it was found to be a nearly full-length cDNA clone of human MT-fl mRNA (8) . The coding region of that cDNA was used as a hybridization probe for detection of human MT (19) .
These observations led us to suggest that (a) heavy metal ions and glucocorticoid hormones increase the transcription rates of MT genes by different mechanisms and (b) heavy metal induction is mediated through the removal of a repressor of MT gene expression. However, as a consequence of metal induction the level of the repressor is increased causing a transient induction response. Inhibition of the synthesis of this putative repressor by cycloheximide causes a large augmentation of the induction response to metal ions. In our simplest working hypothesis the repressor is apothionein (see Fig. 1 ), which explains the specificity of the induction response, since only metal ions that bind to the apoprotein can lead to induction. This induction is due to the conversion of apotheionein, the active repressor form, to metallothionein, the inactive repressor form. After a while, the level of MT in the cell is increased, but so does the level of the apoprotein, the putative repressor, leading to a decrease in the transcription rate of the MT genes, and resulting in a transient induction response. Induction by glucocorticoids bypasses this pathway and leads to persistent activation of the genes, as long as, the hormone receptor complex is bound to DNA (18 More recently we have compared the expression of the MT-IIA and the MT-IA genes in human cells. We find that while the MT-IIA gene is induced to the same extent by Cd2+, Zn2+, Cu2+ and dexamethasone, the MT-IA gene is only fully induced by Cd2+. These results suggest that the various MT genes are regulated differently from each, most likely due to the different functions they serve.
Localization of the Regulatory Elements of Human MT Genes
As indicated, both the human MT-IA and the MT-IIA genes are still inducible by heavy metal ions after transfer into rodent cells on BPV derived sectors (12) . While being appropriate for studying metal induction, this sytem is not suitable for studying the hormonal regulation of cloned MT genes, since the episomal state precludes glucocorticoid induction. On the other hand, cotransfer (with the Herpes simplex virus thymidine kinase gene) of the human MT-IIA gene, into rat fibroblasts leading to stable integration into the host genome, results in retention of full responsiveness to both glucocorticoid hormones and heavy metal ions.
To test whether the regulatory DNA elements controlling MT-IIA gene expression are found within the 800 bp 5' flanking region of the cloned fragment used in the transfection experiments mentioned above, we have fused this region to the structural portion of the Herpes simplex virus (HSV) thymidine kinase (TK) gene. The transcription of TK mRNA from this fusion gene (hMTK) is under the control of the human MT-IIA gene promoter. The hMTK fusion gene was introduced into TK-rat fibroblasts by transfection and selection for the TK+ phenotype. The expression of TK mRNA in those cells was found to be both heavy metal and hormone inducible. These results indicate that the important regulatory elements for both heavy metal and glucocorticoid inductions are found within 800 bp of the 5' flanking region of the human MT-IIA gene. Measuring the rate of synthesis of MTK mRNA under different induction conditions demonstrated transcriptional control by both Cd2+ and dexamethasone (20) . More recently by performing sequential deletions of 5' flanking nucleotides of the hMTK gene we found that only 300 bp are sufficient for maintenance of both hormone and metal induction (M. Karin et al., unpublished) .
Conclusions
By applying recombinant DNA technology to study of structure and function of MT genes in man we were able to demonstrate that: (a) this group of proteins is encoded by a large gene family, (b) different MT genes vary in their response to various inducers, (c) overexpression of MT genes leads to protection of cultured cells against the toxic effect of Cd2+ and (d) the regulatory DNA elements controlling the expression of the human MT-IIA gene are located within 300 bp of 5' flanking DNA whose primary structure is known.
The differences in the response of the MT-IIA and MT-IA gene to various inducers suggest that the two genes have different functions. Since the MT-IIA gene is the one which is highly inducible by glucocorticoids and zinc, we believe this gene serves a homeostatic role. The modulation of MT-II expression by zinc, copper and glucocorticoids help to maintain zinc and copper homeostasis. During periods of high availability, zinc and copper stimulate the transcription of the MT-IIA gene, leading to increased production of MT-II, mostly in the liver, which results in the storage of the excess amounts of those essential trace metals. Glucocorticoids, by increasing the expression of MT-II, cause mobilization of zinc and probably copper from the circulation into the liver and other organs, leading eventually to hypozincemia.
On the other hand, the expression of the MT-IA gene, and possibly of the other MT-I genes, as well, is not highly stimulated by glucocorticoids and zinc or copper. Only cadmium seems to be a potent inducer of those genes. Therefore, we believe the MT-I genes serve a protective role. This hypothesis is supported by the multiplicity of MT-I genes in most mammals except rodents.
Primates have at least four functional MT-I genes (J. Kagi and M. Kimura, personal communications). If all of those genes are activated by Cd2+, this would constitute an efficient protective response, due to a massive increase in the synthesis MT-I resulting in the chelating of the toxic Cd2+ ions.
In the future we plan to further characterize all the different MT genes and study their organization within the genome. We hope to be able to understand the genetic mechanism which has led to the generation of multiple MT-I genes in man. We also plan to investigate whether there are any tissue-specific variations in the expression of the different human MT genes. Finally we hope to be able to reconstitute an in vitro induction system, consisting of cloned MT genes, a few regulatory proteins and RNA polymerase-II. By using such a system it should be possible to determine how heavy metals control gene expression. 
